Congratulations! BiOptic’s core products have successfully registered and listed in FDA!
2023-02-22
BiOptic has recently registered and listed the core products and related consumables in the USA FDA Class I category. Items including Qsep Series Bio-Fragment Analyzers, Qampmini Thermal Cycler and multiple cartridges ,etc. In the future, the above mentioned core products can be sold as medical equipment in the United States, which will expand our business scope in the US market.
The consequences of the coronavirus disease (COVID-19) outbreak are unprecedented and felt around the world. Industries are being profoundly affected by the pandemic. Fortunately, BiOptic Inc. remains high productivity and keeps devoted to technological innovation. The outstanding R&D capabilities allow us to win several Technology Development Program (TDP) from the government and were favored by the committee of Taipei Biotech Awards – Innovation Award in July 2020.
Are you still using traditional spectrophotometry for nucleic acid quantitation?
BiOptic Quantitative Cartridge Kits
• Quantitative Standard Cartridge Kit (C105201-Q)
• Quantitative High-Resolution Cartridge Kit (C105202-Q)
![[Special Promotion by BiOptic USA] Genetic Analysis for Maximum Efficiency](https://www.bioptic.com.tw/archive/news/product news/20221007.jpg)
